Home Menu

Site Navigation



ALS News & Research For postings of news or research links and articles related to ALS

NeuroTalk Support Groups > > > >

Flex Pharma Inc.: Flex Pharma Reports Year End 2016 Financial Results

Reply
 
Thread Tools Display Modes
Old 03-10-2017, 02:10 PM #1
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,380
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,380
15 yr Member
Exclamation Flex Pharma Inc.: Flex Pharma Reports Year End 2016 Financial Results
Flex Pharma Inc.: Flex Pharma Reports Year End 2016 Financial Results

Flex Pharma Inc.: Flex Pharma Reports Year End 216 Financial Results - The Wall Street Transcript
MuonOne is offline   Reply With QuoteReply With Quote
Reply

Tags
financial, flex, pharma, reports, results

« Previous Thread | Next Thread »
Thread Tools
Display Modes
Linear Mode Linear Mode

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
Flex Pharma Shifts Focus to Programs Targeting ALS, Other Neurological Diseases MuonOne ALS News & Research 1 01-27-2017 09:57 AM
Pharma CEO's agree: no market discipline for Pharma prices Bob Dawson Parkinson's Disease 2 05-18-2011 07:56 PM


All times are GMT -5. The time now is 12:38 AM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home